Hematology

  • Dual antiplatelet therapy for acute coronary syndromes: How long to continue?
    Dual antiplatelet therapy for acute coronary syndromes: How long to continue?
    Meghana Halkar, MD and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine September 2016, 83 (9) 675-688; DOI: https://doi.org/10.3949/ccjm.83a.15092

    After drug-eluting stent placement, at least 12 months of dual antiplatelet therapy is recommended. Would longer be better?

  • Your patient has chronic leukemia: Now what?
    Matt Kalaycio, MD, FACP
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 575-581; DOI: https://doi.org/10.3949/ccjm.83gr.16002

    New therapies for chronic myelogenous leukemia and chronic lymphocytic leukemia are increasing the number of survivors.

  • Anemia of chronic kidney disease: Treat it, but not too aggressively
    Anemia of chronic kidney disease: Treat it, but not too aggressively
    Georges Nakhoul, MD and James F. Simon, MD
    Cleveland Clinic Journal of Medicine August 2016, 83 (8) 613-624; DOI: https://doi.org/10.3949/ccjm.83a.15065

    Renal anemia is associated with bad outcomes, but attempting to normalize hemoglobin levels can be harmful.

  • Are we causing anemia by ordering unnecessary blood tests?
    Carlo Lutz, MD and Hyung J. Cho, MD
    Cleveland Clinic Journal of Medicine July 2016, 83 (7) 496-497; DOI: https://doi.org/10.3949/ccjm.83a.15108

    Iatrogenic anemia from blood draws is common, serious, and unnecessary.

  • In reply: Vitamin B12 deficiency (July 2015)
    Douglas L. Nguyen, MD, Shelly Maithel, Alex K. Duong and Jonathan Zhang, MD
    Cleveland Clinic Journal of Medicine January 2016, 83 (1) 15; DOI: https://doi.org/10.3949/ccjm.83c.01002
  • Vitamin B12 deficiency (July 2015)
    Kenneth R. Phillips, MS, MD, FCCP
    Cleveland Clinic Journal of Medicine January 2016, 83 (1) 15; DOI: https://doi.org/10.3949/ccjm.83c.01001

    Readers comment on vitamin B12 defi ciency (July 2015) and on preoperative testing (October 2015).

  • Approach to asymptomatic creatine kinase elevation
    Siamak Moghadam-Kia, MD, Chester V. Oddis, MD and Rohit Aggarwal, MD, MS
    Cleveland Clinic Journal of Medicine January 2016, 83 (1) 37-42; DOI: https://doi.org/10.3949/ccjm.83a.14120

    Standard cutoffs may be too low. First, repeat the test after 7 days without exercise.

Pages